ARGX earnings date and last-quarter result: next report 2026-07-23, last quarter beat, P/E 50.16. Updated 2026-07-23.
argenx (ARGX) Research Hub
argenx (ARGX) trades on NASDAQ, NL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 869.33 USD (-0.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 50.16, market cap 53.37B. This hub links to the full technical, earnings and options research available for ARGX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, NL |
| Last close | 869.33 USD (-0.50%) |
| 52-week range | 787.73 USD – 1,070.81 USD |
| Trend regime | Range |
| 14-day RSI | 39.9 (Bearish) |
| Trailing P/E | 50.16 |
| Market cap | 53.37B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-23 |
Available research for ARGX
Covered Call on ARGX: how it works, illustrative setup around the real 869.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARGX: how it works, illustrative setup around the real 869.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARGX: how it works, illustrative setup around the real 869.33 USD price, max profit/loss, breakeven and when to use it. Educational.
ARGX technical analysis: range, last 869.33 USD, RSI 39.9, 52w range 787.73 USD–1,070.81 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ARGX in?
argenx (ARGX) is classified under Healthcare (Biotechnology), listed on NASDAQ, NL.
Is ARGX in an uptrend or downtrend?
As of 2026-10-26, ARGX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARGX's trailing P/E ratio?
ARGX's trailing P/E is 50.16, with a market cap of 53.37B. See the earnings research page for full valuation detail.
When does ARGX next report earnings?
ARGX is next scheduled to report earnings on 2026-07-23.